32 results on '"Schneeweis, Christian"'
Search Results
2. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer
3. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment
4. NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer
5. AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
6. A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer
7. Important role of Nfkb2 in the KrasG12D-driven carcinogenesis in the pancreas
8. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction.
9. The SUMO pathway in pancreatic cancer: insights and inhibition
10. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer
11. Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505]
12. MTOR inhibitor-based combination therapies for pancreatic cancer
13. The Role of FRA1 and SUMOylation in Pancreatic Cancer
14. Die Rolle von FRA1 und SUMOylierung im Pankreaskarzinom
15. AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
16. Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype
17. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells
18. Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
19. Abstract 2475: Differential sensitivity of mouse PDAC KrasG12Dcells to Ref-1/APE1 redox signalling inhibitors: Role of NFkB as a primary target of Ref-1/APE1 inKrasdriven pancreatic ductal adenocarcinoma
20. Targeting the ubiquitin���proteasome system in a pancreatic cancer subtype with hyperactive MYC
21. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
22. Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
23. The SUMO pathway in pancreatic cancer: insights and inhibition
24. Abstract 1793: Interaction of MYC and SUMOylation machinery in an aggressive pancreatic cancer subtype
25. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
26. Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
27. Adaptive rewiring of oncogenic signalling upon MTOR deletion in pancreatic cancer
28. Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes
29. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
30. Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes.
31. KRASG12C‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening.
32. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.